Spots Global Cancer Trial Database for aranesp
Every month we try and update this database with for aranesp cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
| ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer | NCT00261313 | Breast Cancer | Neulasta Aranesp | 18 Years - | Amgen | |
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | NCT00858364 | Non-Small Cell ... Anemia Cancer Lung Cancer | Darbepoetin alf... Placebo | 18 Years - | Amgen | |
| A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® | NCT00117117 | Anemia | Aranesp | 18 Years - | Amgen | |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
| Study of Aranesp to Treat Anemia in Prostate Cancer Patients. | NCT00245895 | Prostate Cancer Anemia | Aranesp | - | University of Washington | |
| ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer | NCT00261313 | Breast Cancer | Neulasta Aranesp | 18 Years - | Amgen | |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
| Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation | NCT00355407 | Hematologic Mal... | Darbepoetin alf... | 18 Years - | Dana-Farber Cancer Institute | |
| Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide | NCT00283621 | Sarcoma | Aranesp (darbep... Neulasta (pegfi... Adriamycin Ifosfamide | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | NCT01444456 | Anemia Breast Cancer Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Prostate Cancer Solid Tumors Bladder Cancer Endometrial Can... Renal Cancer Pancreatic Canc... Esophageal Canc... Gastric Cancer | 18 Years - | Amgen | ||
| Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS | NCT00520468 | Myelodysplastic... | Erythropoietin Cyclosporin A G-CSF Prednisone | - | M.D. Anderson Cancer Center | |
| Darbepoetin Alfa and Anemia of Cancer | NCT00989092 | Anemia Anemia of Cance... Cancer Carcinoma Neoplasms Non-Myeloid Mal... | darbepoetin alf... | 18 Years - | Amgen | |
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | NCT00858364 | Non-Small Cell ... Anemia Cancer Lung Cancer | Darbepoetin alf... Placebo | 18 Years - | Amgen | |
| Study of Aranesp to Treat Anemia in Prostate Cancer Patients. | NCT00245895 | Prostate Cancer Anemia | Aranesp | - | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
